Cambridge-based startup Mersana Therapeutics said today that it raised $75 million in an initial public offering.
The company sold 5 million shares of common stock at $15 apiece. Mersana, which debuted on the Nasdaq exchange listed under “MRSN”, also gave underwriters a 30-day option to buy up to 750,000 more shares at $15 per share.
Get the full story at our sister site, Drug Delivery Business News.
The post Mersana Therapeutics prices $75m IPO appeared first on MassDevice.
from MassDevice http://ift.tt/2tqbaWb
Cap comentari:
Publica un comentari a l'entrada